Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
about
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationTranscriptional regulation of chemokine expression in ovarian cancerCCR9 in cancer: oncogenic role and therapeutic targetingCCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist.The role of chemoattractant receptors in shaping the tumor microenvironment.Quantitative histopathological assessment of ocular surface squamous neoplasia using digital image analysis.Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisA high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytesCXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.Chemokines and their receptors in lung cancer progression and metastasis.CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition.Differential Expression of Chemokine Receptors and their Roles in Cancer Imaging.CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells.
P2860
Q26796395-BBEAF0C7-F8F0-4528-8D30-F47E29DDCE5AQ26825361-F23E1F35-D013-4633-8FAE-5C28EC2FCDAFQ28066712-F168F8E5-B5EE-4BDF-957C-B327BDC2E471Q33907480-21537123-A4E6-4564-BC0F-645A79647025Q33993124-1FCAEB45-A4FC-4492-AAE3-5881094E3EE0Q34141457-D583AC02-BA1B-4AFE-A798-0057FF9F5FA8Q34223860-8B0BBFDC-0BD2-44C2-9942-B642C4BA15E3Q34654463-83086463-1EA3-485E-B4B6-6F7F9EB00ABDQ35483823-DF3F6901-BD50-4C3E-B368-B47A562F13EFQ35833218-9475BF74-C034-44C8-AE15-5D0328A35263Q36838437-7FAC4223-C4A3-433A-98E9-218A913E46FEQ36906094-A6D8BD27-0759-451F-89FE-AC711F0EECF8Q37174010-BAAB5072-6FA0-4398-AA62-74D26289C2D3Q38015856-290F7428-717B-4DDD-8C15-2CC38F118EBDQ48527882-FB6AF26D-2FD9-410A-B28D-8F9E5941B278
P2860
Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
@en
Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
@nl
type
label
Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
@en
Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
@nl
prefLabel
Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
@en
Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
@nl
P2093
P2860
P356
P1476
Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
@en
P2093
Cecil R Stockard
James W Lillard
Rajesh Singh
Shailesh Singh
William E Grizzle
P2860
P304
P356
10.3892/IJO.2011.1059
P577
2011-05-31T00:00:00Z